These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30927235)

  • 1. Family-based association study on functional α-synuclein polymorphisms in attention-deficit/hyperactivity disorder.
    Gerlach M; Sharma M; Romanos M; Lesch KP; Walitza S; Conzelmann HA; Krüger R; Renner TJ
    Atten Defic Hyperact Disord; 2019 Mar; 11(1):107-111. PubMed ID: 30927235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson's disease.
    Emelyanov A; Kulabukhova D; Garaeva L; Senkevich K; Verbitskaya E; Nikolaev M; Andoskin P; Kopytova A; Milyukhina I; Yakimovskii A; Timofeeva A; Prakhova L; Ilves A; Vlasova I; Pchelina S
    J Neurol Sci; 2018 Dec; 395():135-140. PubMed ID: 30316070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [SNCA rs356219 AND rs356165 VARIANTS ARE ASSOCIATED WITH PARKINSON'S DISEASE AND INCREASED ALPHA-SYNUCLEIN GENE EXPRESSION IN THE CD45(+)-BLOOD CELLS].
    Emelyanov AK; Andoskin PA; Miliukhina IV; Timofeeva AA; Yakimovskii AF; Senkevich KA; Nikolaev MA; Pchelina SN
    Tsitologiia; 2016; 58(2):99-104. PubMed ID: 27228655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.
    Mata IF; Shi M; Agarwal P; Chung KA; Edwards KL; Factor SA; Galasko DR; Ginghina C; Griffith A; Higgins DS; Kay DM; Kim H; Leverenz JB; Quinn JF; Roberts JW; Samii A; Snapinn KW; Tsuang DW; Yearout D; Zhang J; Payami H; Zabetian CP
    Arch Neurol; 2010 Nov; 67(11):1350-6. PubMed ID: 21060011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?
    Markopoulou K; Biernacka JM; Armasu SM; Anderson KJ; Ahlskog JE; Chase BA; Chung SJ; Cunningham JM; Farrer M; Frigerio R; Maraganore DM
    Parkinsonism Relat Disord; 2014 Jun; 20(6):584-9; discussion 584. PubMed ID: 24656894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage disequilibrium and association analysis of alpha-synuclein and alcohol and drug dependence in two American Indian populations.
    Clarimon J; Gray RR; Williams LN; Enoch MA; Robin RW; Albaugh B; Singleton A; Goldman D; Mulligan CJ
    Alcohol Clin Exp Res; 2007 Apr; 31(4):546-54. PubMed ID: 17374033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system.
    Chiba-Falek O; Nussbaum RL
    Hum Mol Genet; 2001 Dec; 10(26):3101-9. PubMed ID: 11751692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population.
    Myhre R; Toft M; Kachergus J; Hulihan MM; Aasly JO; Klungland H; Farrer MJ
    Acta Neurol Scand; 2008 Nov; 118(5):320-7. PubMed ID: 18485051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NACP-REP1 polymorphism is not involved in Parkinson's disease: a case-control study in a population sample from southern Italy.
    Spadafora P; Annesi G; Pasqua AA; Serra P; Cirò Candiano IC; Carrideo S; Tarantino P; Civitelli D; De Marco EV; Nicoletti G; Annesi F; Quattrone A
    Neurosci Lett; 2003 Nov; 351(2):75-8. PubMed ID: 14583385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample.
    Renner TJ; Nguyen TT; Romanos M; Walitza S; Röser C; Reif A; Schäfer H; Warnke A; Gerlach M; Lesch KP
    Atten Defic Hyperact Disord; 2011 Sep; 3(3):285-9. PubMed ID: 21739117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene.
    Chiba-Falek O; Touchman JW; Nussbaum RL
    Hum Genet; 2003 Oct; 113(5):426-31. PubMed ID: 12923682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNP rs356219 of the α-synuclein (SNCA) gene is associated with Parkinson's disease in a Chinese Han population.
    Pan F; Dong H; Ding H; Ye M; Liu W; Wu Y; Zhang X; Chen Z; Luo Y; Ding X
    Parkinsonism Relat Disord; 2012 Jun; 18(5):632-4. PubMed ID: 22349157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-syn and SNP rs356219 as a potential biomarker in blood for Parkinson's disease in Mexican Mestizos.
    Salas-Leal AC; Salas-Pacheco SM; Gavilán-Ceniceros JAP; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Camacho-Luis A; Quiñones-Canales G; Romero-Gutiérrez E; Arias-Carrión O; Salas-Pacheco JM; Sandoval-Carrillo AA
    Neurosci Lett; 2021 May; 754():135901. PubMed ID: 33865938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.
    Kustanovich V; Ishii J; Crawford L; Yang M; McGough JJ; McCracken JT; Smalley SL; Nelson SF
    Mol Psychiatry; 2004 Jul; 9(7):711-7. PubMed ID: 14699430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of alpha-synuclein gene haplotypes with Parkinson's disease.
    Parsian AJ; Racette BA; Zhao JH; Sinha R; Patra B; Perlmutter JS; Parsian A
    Parkinsonism Relat Disord; 2007 Aug; 13(6):343-7. PubMed ID: 17292657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene.
    Chiba-Falek O; Kowalak JA; Smulson ME; Nussbaum RL
    Am J Hum Genet; 2005 Mar; 76(3):478-92. PubMed ID: 15672325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ASTN2 variants in childhood and adult ADHD, comorbid disorders and associated personality traits.
    Freitag CM; Lempp T; Nguyen TT; Jacob CP; Weissflog L; Romanos M; Renner TJ; Walitza S; Warnke A; Rujescu D; Lesch KP; Reif A
    J Neural Transm (Vienna); 2016 Aug; 123(8):849-58. PubMed ID: 27138430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the G protein subunit Galphaolf gene (GNAL) in attention deficit/hyperactivity disorder.
    Laurin N; Ickowicz A; Pathare T; Malone M; Tannock R; Schachar R; Kennedy JL; Barr CL
    J Psychiatr Res; 2008 Jan; 42(2):117-24. PubMed ID: 17166517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between serotonin 2C gene polymorphisms and attention deficit hyperactivity disorder in children with or without comorbidity of disruptive behavior disorder].
    Li J; Wang YF; Zhou RL; Yang L; Zhang HB; Wang B
    Zhonghua Er Ke Za Zhi; 2007 May; 45(5):374-7. PubMed ID: 17697626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-synuclein repeat variants and survival in Parkinson's disease.
    Chung SJ; Biernacka JM; Armasu SM; Anderson K; Frigerio R; Aasly JO; Annesi G; Bentivoglio AR; Brighina L; Chartier-Harlin MC; Goldwurm S; Hadjigeorgiou G; Jasinska-Myga B; Jeon BS; Kim YJ; Krüger R; Lesage S; Markopoulou K; Mellick G; Morrison KE; Puschmann A; Tan EK; Crosiers D; Theuns J; Van Broeckhoven C; Wirdefeldt K; Wszolek ZK; Elbaz A; Maraganore DM;
    Mov Disord; 2014 Jul; 29(8):1053-7. PubMed ID: 24578302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.